Covered recipient · General Payments record
SUMEET MATHUR
Allopathic & Osteopathic Physicians Otolaryngology Plastic Surgery within the Head & Neck
General Payments · PY2018–2024
$13,292.04
- Reported across 145 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,060.00 | 1 |
| Food and Beverage | $647.87 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $1,205.07 | 5 |
| Stryker Corporation | $211.11 | 2 |
| GlaxoSmithKline, LLC. | $103.40 | 1 |
| Regeneron Healthcare Solutions, Inc. | $94.28 | 1 |
| Acclarent, Inc | $94.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Acclarent, Inc | $94.01 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077575756 | CMS |
| GENZYME CORPORATION | $4.75 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139669088 | CMS |
| GENZYME CORPORATION | $6.12 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139669124 | CMS |
| GENZYME CORPORATION | $12.55 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139669132 | CMS |
| GENZYME CORPORATION | $121.65 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139669154 | CMS |
| GENZYME CORPORATION | $1,060.00 | 10/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139669196 | CMS |
| GlaxoSmithKline, LLC. | $103.40 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115834414 | CMS |
| Regeneron Healthcare Solutions, Inc. | $94.28 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114109985 | CMS |
| Stryker Corporation | $124.69 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119908423 | CMS |
| Stryker Corporation | $86.42 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119908425 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.